A Phase I/II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients With Advanced Stage Diffuse Large B-Cell Lymphomas.
Phase of Trial: Phase I/II
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 02 Jun 2010 Planned end date changed from 1 Apr 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 08 Nov 2006 New trial record.